Yu Jeffrey
Yu Jeffrey, CMO, reported an open-market or private purchase at OneMedNet Corp involving 45126.000000 shares for an estimated $249998.04. Reported holdings after the transaction were 896840.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 09, 2026
- Filing date
- Oct 14, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 851,714 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ONMD price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001493152-26-046908 Common Stock
- Transaction date
- Oct 09, 2026 Filed Oct 14, 2026, 12:32 AM · 5d delay
- Shares
- 45,126 sh $5.54 per share
- Estimated value
- $249k Computed from shares × price
- Holdings after
- 896,840 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+38 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - director_buy+6 points
is_director = true
Director open-market purchase. - cluster_buy+14 points
cluster-buy signal matched
Multiple insiders bought within the configured window.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Medical Officer
- F1
On October 9, 2026, the issuer entered into a subscription agreement with the reporting person for a $250,000 investment in the issuer.
- F2
The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.
- F3
The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report…
0 other transactions
0 recent txs